BPC-157
BPC-157
BPC-157 5 mg – Research Peptide
Stable Gastric Pentadecapeptide for Scientific Research
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide that has attracted scientific interest for its potential involvement in tissue-repair biology, gastrointestinal research, angiogenic signaling, cellular migration and musculoskeletal experimental models.
The peptide has been investigated predominantly in preclinical models involving the gastrointestinal tract, tendon, ligament, skeletal muscle, skin and vascular systems.
Experimental studies have explored several biological pathways potentially associated with BPC-157, including VEGF-related signaling, nitric oxide pathways, cellular migration, angiogenesis and extracellular matrix remodeling. However, the available evidence is predominantly preclinical, and findings from animal or laboratory studies should not be interpreted as established therapeutic effects in humans.
ICAME Pharmacy BPC-157 is intended strictly for laboratory research and development purposes. It is not intended for human or veterinary use.
What is BPC-157?
BPC-157 is a pentadecapeptide consisting of 15 amino acids.
Its commonly reported amino-acid sequence is:
GEPPPGKPADDAGLV
BPC-157 has been described in scientific literature as a stable gastric pentadecapeptide and has been investigated in experimental models examining cytoprotection, tissue injury and repair mechanisms.
Unlike many research peptides centered primarily on endocrine receptor signaling, BPC-157 research has focused extensively on cellular responses to tissue damage and the molecular pathways associated with tissue remodeling.
Scientific Interest in BPC-157
The scientific interest surrounding BPC-157 originates largely from experimental observations across several tissue types.
Preclinical studies have investigated its effects in models involving:
Tendons • Ligaments • Skeletal Muscle • Gastrointestinal Tissue • Skin • Blood Vessels
This has led researchers to investigate whether common molecular mechanisms may connect the biological responses observed across these different experimental systems.
BPC-157 and Tissue-Repair Research
One of the most extensively investigated areas involving BPC-157 is experimental tissue-repair biology.
Tissue repair is a complex biological process requiring coordinated interactions between cells, extracellular matrix components, signaling molecules and blood vessels.
A simplified research model includes:
Tissue Injury
↓
Cell Migration & Signaling
↓
Vascular Response
↓
Extracellular Matrix Organization
↓
Tissue Remodeling
BPC-157 has been investigated at several stages within these processes in animal and cellular experimental models.
Published research includes experimental models involving tendon, ligament, muscle and wound repair.
Tendon Research
Tendon biology represents one of the best-known experimental research areas involving BPC-157.
In a rat model involving surgically transected Achilles tendons, researchers reported changes in biomechanical, functional, microscopic and macroscopic measures of tendon repair following experimental BPC-157 administration.
The researchers also reported effects on tendocyte growth in laboratory experiments.
Other animal research has examined tendon-to-bone healing, including experimental Achilles tendon detachment models.
These findings remain preclinical observations from animal models and do not establish efficacy for tendon injuries in humans.
Ligament Research
BPC-157 has also been investigated in experimental ligament injury.
A study involving surgically transected medial collateral ligaments in rats examined functional, biomechanical, macroscopic and histological outcomes over a period of up to 90 days.
The study reported differences in several healing-related parameters in BPC-157-treated animals compared with controls.
Such research provides a basis for studying molecular pathways involved in ligament remodeling and connective-tissue biology, but does not demonstrate a clinically established treatment effect in humans.
Angiogenesis and VEGF Research
Angiogenesis—the formation and remodeling of blood vessels—is an important component of tissue repair.
One experimental study investigated the relationship between BPC-157 and vascular endothelial growth factor (VEGF) in muscle and tendon healing models.
The researchers did not observe a direct angiogenic effect in the tested cell cultures. However, animal tissue analysis suggested that BPC-157-associated angiogenic responses during healing may involve changes in VEGF expression.
This has contributed to scientific interest in the relationship between:
BPC-157
↓
VEGF-Associated Signaling
↓
Vascular Response
↓
Experimental Tissue Remodeling
The precise mechanisms remain an active area of investigation.
Gastrointestinal Research
The gastrointestinal system represents another major area of BPC-157 research.
BPC-157 has historically been investigated in experimental models involving gastric cytoprotection, gastrointestinal lesions and tissue integrity.
Research reviews describe experimental investigations across different portions of the gastrointestinal tract and explore potential relationships between vascular integrity, epithelial protection and tissue-repair mechanisms.
This gastrointestinal research has also contributed to broader hypotheses concerning BPC-157 and tissue protection outside the digestive system.
Cell Migration and Cytoskeletal Research
Successful tissue remodeling depends heavily on the ability of cells to migrate toward damaged areas.
Experimental research has therefore examined potential relationships between BPC-157 and cellular migration pathways.
These mechanisms are relevant to researchers investigating:
Fibroblast Migration
Endothelial Cell Behavior
Extracellular Matrix Organization
Cytoskeletal Dynamics
Cellular Responses to Tissue Injury
Understanding these processes may help clarify why biological responses have been observed across different experimental tissue models.
Extracellular Matrix and Collagen Research
The extracellular matrix (ECM) provides structural and biochemical support for surrounding cells and plays a central role in tissue organization.
Collagen is particularly important in connective tissues such as tendons and ligaments.
Experimental tendon and ligament studies involving BPC-157 have reported changes involving fibroblasts, collagen organization and biomechanical properties during tissue repair.
This makes BPC-157 relevant to experimental investigations involving connective-tissue remodeling and extracellular matrix biology.
Musculoskeletal Research
BPC-157 has generated considerable interest in experimental musculoskeletal research.
Preclinical investigations have examined models involving:
Tendon Injury
Ligament Injury
Skeletal Muscle Injury
Tendon-to-Bone Interfaces
Connective-Tissue Remodeling
A published review examining this field concluded that the available studies reported promising experimental observations, but emphasized that most research had been performed in small rodent models and that efficacy remained to be confirmed in humans.
This limitation is important when interpreting BPC-157 research.
Potential Research Applications
BPC-157 may be of interest for controlled laboratory investigations involving:
- Tissue-repair biology
- Tendon research
- Ligament research
- Skeletal muscle research
- Gastrointestinal tissue biology
- Angiogenesis research
- VEGF-associated signaling
- Cell migration studies
- Extracellular matrix research
- Collagen organization
- Fibroblast biology
- Vascular response research
- Wound-healing models
- Regenerative biology
- Experimental pharmacology
Specific suitability for individual experimental protocols should be established by qualified researchers using appropriate analytical and batch-specific documentation.
Proposed Areas of Mechanistic Research
The mechanism of BPC-157 is not fully established.
Current experimental literature has explored several interconnected pathways rather than identifying a single definitive molecular target.
A simplified representation of areas under investigation can be presented as:
BPC-157
↓
Cellular & Molecular Signaling
↓
VEGF / Vascular Signaling • Cell Migration • Cytoskeletal Activity
↓
Fibroblast & Extracellular Matrix Responses
↓
Experimental Tissue Remodeling
This model should be understood as a representation of research hypotheses and preclinical observations, rather than an established mechanism of therapeutic action.
Scientific Evidence and Limitations
BPC-157 has accumulated a substantial body of experimental literature, particularly involving animal models of gastrointestinal and musculoskeletal tissue injury.
However, there are important limitations.
Much of the evidence comes from animal studies, particularly rodent models, and several areas of the BPC-157 literature originate from a relatively concentrated group of investigators. Independent replication and robust human clinical evidence remain limited. A review of musculoskeletal research specifically noted that efficacy has yet to be confirmed in humans.
Consequently, results involving experimental tissue repair should not be presented as evidence that BPC-157 can diagnose, prevent or treat injuries or diseases in humans.
Product Information
Product Name: BPC-157
Brand: ICAME Pharmacy
Sequence: GEPPPGKPADDAGLV
Peptide Length: 15 amino acids
Product Category: Research Peptide
Research Classification: Stable Gastric Pentadecapeptide
Research Areas: Tissue Biology / Gastrointestinal Research / Musculoskeletal Research / Cellular & Vascular Research
Intended Use: Laboratory Research & Development Only
Batch-specific information including purity, analytical methodology, Certificate of Analysis (COA), molecular identity, batch/lot identification and validated storage conditions should be provided according to the documentation associated with each individual production batch.
Important Research Use Notice
FOR RESEARCH USE ONLY (RUO)
This product is intended exclusively for legitimate laboratory, analytical and scientific research purposes.
Not for human or veterinary use. Not for diagnostic, therapeutic, prophylactic, injury-recovery or performance-enhancing purposes. Not for direct administration to humans or animals.
BPC-157 should not be represented as an approved medicinal treatment based on preclinical findings.
Information provided on this page is intended solely for scientific and educational purposes and should not be interpreted as medical advice, prescribing information, dosage guidance or evidence of established clinical safety or efficacy.
For competitive-sport contexts, BPC-157 is also specifically named by the World Anti-Doping Agency under the category of non-approved substances prohibited at all times.
About ICAME Pharmacy
ICAME Pharmacy provides specialized research products intended for professional laboratory and scientific applications.
Our research portfolio focuses on compounds relevant to contemporary areas of molecular biology, cellular research, regenerative biology, metabolic science and experimental life sciences.
Product information is presented with an emphasis on responsible research use, scientific transparency and a clear distinction between preclinical experimental findings and established clinical evidence.
For batch-specific documentation, analytical information and product inquiries, please contact ICAME Pharmacy.